ARECOR THERAPEUTICS PLC

Active United Kingdom

Activities of other holding companies n.e.c.

44 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
A

ARECOR THERAPEUTICS PLC

Activities of other holding companies n.e.c.

Founded 13 Apr 2021 Active United Kingdom 44 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.

Previous Company Names

ARECOR THERAPEUTICS LIMITED 13 Apr 2021 — 26 May 2021
Accounts Submitted 11 May 2026 Next due 30 Jun 2026 1 month remaining
Confirmation Submitted 8 May 2026 Next due 26 Apr 2027 11 months remaining
Net assets £5M £4M 2024 year on year
Total assets £9M £7M 2024 year on year
Total Liabilities £3M £2M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for ARECOR THERAPEUTICS PLC (13331147), an active life sciences and medical technology company based in United Kingdom. Incorporated 13 Apr 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2018–2024)

Cash in Bank

£3.26M

Decreased by £3.50M (-52%)

Net Assets

£5.35M

Decreased by £4.18M (-44%)

Total Liabilities

£3.37M

Decreased by £2.48M (-42%)

Turnover

£5.32M

Decreased by £400.00k (-7%)

Employees

44

Decreased by 6 (-12%)

Debt Ratio

39%

Increased by 1 (+3%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

12 Allotments 35,104,875 Shares £26.61m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Aug 20247,129,615£6.42m£0.9
31 Oct 20231,332£13.32£0.01
8 Jun 20237,471£74.71£0.01
11 Nov 2022131,433£1k£0.01
29 Oct 2021151,492£2k£0.01

Officers

Officers

2 active 1 resigned
Status
David EllamSecretaryUnknownUnknown19 Dec 2024Active
Howell, Sarah Jennifer, Dr.DirectorBritishEngland5013 Apr 2021Active

Shareholders

Shareholders (24)

Bgf Investment Management Limited
12.3%
Unilever Plc
9.6%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Sarah Howell

Ceased 24 May 2021

Ceased

Group Structure

Group Structure

ARECOR THERAPEUTICS PLC Current Company
TETRIS PHARMA LTD united kingdom
ARECOR LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 May 2026AccountsAnnual accounts made up to 31 Dec 2025
8 May 2026Confirmation StatementConfirmation statement made on 12 Apr 2026 with no updates
28 Apr 2026OfficersChange to director Andrew Richards on 27 Apr 2026
30 Sept 2025OfficersAppointment of Mr Simon John Ormiston as director on 29 Sept 2025
29 Sept 2025OfficersAppointment of Mr David John Ellam as director on 29 Sept 2025
11 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

8 May 2026 Confirmation Statement

Confirmation statement made on 12 Apr 2026 with no updates

28 Apr 2026 Officers

Change to director Andrew Richards on 27 Apr 2026

30 Sept 2025 Officers

Appointment of Mr Simon John Ormiston as director on 29 Sept 2025

29 Sept 2025 Officers

Appointment of Mr David John Ellam as director on 29 Sept 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

5 days ago on 11 May 2026

Confirmation statement made on 12 Apr 2026 with no updates

1 weeks ago on 8 May 2026

Change to director Andrew Richards on 27 Apr 2026

2 weeks ago on 28 Apr 2026

Appointment of Mr Simon John Ormiston as director on 29 Sept 2025

7 months ago on 30 Sept 2025

Appointment of Mr David John Ellam as director on 29 Sept 2025

7 months ago on 29 Sept 2025